Botulinum Toxin, Immunologic Considerations with Long-Term Repeated Use, with Emphasis on Cosmetic Applications

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 1, 2007, Pages 11-16

  Borodic, Gary ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; CASE REPORT; DRUG APPROVAL; DRUG INDICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTHETIC SURGERY; FEMALE; HUMAN; IMMUNOGENICITY; LONG TERM CARE; REPEATED DRUG DOSE; REVIEW; TREATMENT DURATION; WESTERN BLOTTING;

ADULT; ANTIBODY FORMATION; ANTIGENS; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACIAL MUSCLES; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; PERIODICITY; SKIN AGING; TACHYPHYLAXIS;

EID: 33847048170     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.10.001     Document Type: Review

References (17)

1. Schantz E. Therapy with botulinum toxin (1994), Marcel Dekker, New York
2. Borodic G.E., Johnson E., Goodnough M., et al. Botulinum toxin: immunologic resistance and problems with available materials. [by invitation]. Neurology 46 (1996) 26-29
3. Borodic G.E., Ferrante R.J., Pearce B., et al. Pharmacology and histology of botulinum toxin. In: Jankovic J., and Hallet M. (Eds). Therapy with botulinum toxin (1994), Marcel Dekker, New York
4. Borodic G.E., Pearce L.B., and Johnson E. Botulinum toxin antibodies after repetitive eyelid injections. Ophthalmology 101 (1994) 1158-1159
5. Borodic G.E., Pearce L.B., Duane D., et al. Antibodies to botulinum toxin. Neurology 45 1 (1995) 204
6. Package insert to Botox (therapeutic, botulinum type A), United States Version.
7. Package insert to Myobloc, botulinum type B, United States Version.
8. Hathaway C., and Dang C. Immunogenicity of neurotoxins of Clostridium botulinum. In: Jankovic J., and Hallet (Eds). Therapy with botulinum toxin (1994), Marcel Dekker, New York
9. Package insert, Botox Cosmetic, botulinum type A.
10. Johnson E., Acquadro M., and Borodic G. Medical applications of botulinum neurotoxins. In: Alouf J., and Popoff M. (Eds). The comprehensive sourcebook of bacterial protein toxins (2006), Academic Press, London
11. Zuber M., Sebald M., Bathien N., et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43 9 (1993) 1715-1718
12. Dressler D. New formulation of BOTOX: complete antibody-induced therapy failure in hemifacial spasm. J Neurol 251 3 (2004) 360
13. Borodic G.E. Immunologic resistance after repeated botulinum type A injections for facial rhytides. Ophthal Plast Reconstr Surg 22 3 (2006) 239-240
14. Borodic G.E. Botulinum toxin: issues and applications. Curr Opin Otolaryngol Head Neck Surg 7 (1999) 219-225
15. Hanna P.A., Jankovic J., and Vincent A. Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies. J Neurol Neurosurg Psychiatry 66 (1999) 612-616
16. Hanna P.A., and Jonkovic J. Mouse bioassay versus Western blot assay for botulinum antibodies: correlation with clinical response. Neurology 50 6 (1998) 1624-1629
17. Jankovic J., Vuong K.D., and Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. J Neurol 60 7 (2003) 1186-1188